QumulusAI director granted 15,621 RSUs

QumulusAI director Homaira Akbari was granted a total of time-vested restricted stock units under the 2026 Equity Incentive Plan, increasing her unvested equity position.

Rhea-AI Filing Summary

QumulusAI, Inc. (symbol: QMLS) is the issuer of record for a Form 4 filing submitted to the SEC. Akbari Dr. Homaira reported acquisition or exercise transactions in this Form 4 filing.

QumulusAI, Inc. (QMLS) reported that director Dr. Homaira Akbari received two equity awards of common stock on September 1, 2026. One award covers 9,583 restricted stock units vesting partly on October 1, 2026 and then quarterly, and another award covers 6,038 restricted stock units vesting on October 1, 2026. After these grants, Dr. Akbari has 15,621 shares subject to vesting under the company’s 2026 Equity Incentive Plan, with no Rule 10b5-1 trading plan noted.

Insider Trade Summary

Grant/Award: 15,621 shares

Grant/Award 2 txns

Insider Akbari Dr. Homaira

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	9,583	$0.00	$0.00
Grant/Award	Common Stock F2, F3	6,038	$0.00	$0.00

Holdings After Transaction: Common Stock — 15,621 shares (Direct)

Footnotes (3)

1. F1. These shares vest with respect to 3,162 shares on October 1, 2026 and with respect to 8.375% of the remaining shares quarterly over 8 quarters commencing January 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI, Inc. through the applicable vesting date.
2. F2. These shares vest on October 1, 2026 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.
3. F3. Includes 15,621 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates.

Key Figures

Restricted stock units granted: 9,583 shares Additional restricted stock units granted: 6,038 shares Unvested RSU shares after grants: 15,621 shares +3 more

6 metrics

Restricted stock units granted 9,583 shares RSU award to Dr. Homaira Akbari on September 1, 2026 under the 2026 Equity Incentive Plan

Additional restricted stock units granted 6,038 shares Second RSU award to Dr. Homaira Akbari on September 1, 2026 vesting October 1, 2026

Unvested RSU shares after grants 15,621 shares Total shares to be issued upon vesting of RSUs held by Dr. Akbari

Initial vesting tranche 3,162 shares Portion of 9,583 RSUs vesting on October 1, 2026

Quarterly vesting rate 8.375% Percentage of remaining RSUs from the 9,583-share grant vesting each quarter over 8 quarters

Per-share grant price $0.00 per share Reported grant price for both RSU awards to Dr. Akbari

Key Terms

restricted stock unit, Equity Incentive Plan, vesting

3 terms

restricted stock unit financial

"These shares vest with respect to 3,162 shares on October 1, 2026 pursuant to a restricted stock unit award"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Equity Incentive Plan financial

"pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

vesting financial

"These shares vest with respect to 3,162 shares on October 1, 2026 and with respect to 8.375% of the remaining shares quarterly"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did QumulusAI (QMLS) grant to Dr. Homaira Akbari?

Dr. Homaira Akbari received 9,583 restricted stock units and a separate award of 6,038 restricted stock units of QumulusAI common stock on September 1, 2026, both granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.

How do the 9,583 QMLS restricted stock units granted to Dr. Akbari vest?

Of the 9,583 restricted stock units, 3,162 vest on October 1, 2026, and 8.375% of the remaining units vest quarterly over 8 quarters starting January 1, 2027, conditioned on her continuing to serve as a director through each vesting date.

When do the additional 6,038 QMLS restricted stock units vest for Dr. Akbari?

The additional award of 6,038 restricted stock units vests in full on October 1, 2026, pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.

How many unvested QMLS shares does Dr. Akbari hold after these grants?

After these awards, Dr. Akbari holds 15,621 shares subject to issuance upon vesting of restricted stock unit awards under the QumulusAI, Inc. 2026 Equity Incentive Plan, contingent on her continued service as a director through the applicable vesting dates.

Did Dr. Akbari purchase QMLS shares on the market in this Form 4 filing?

No. The Form 4 reports grant or award acquisitions of restricted stock units with a stated price of $0.00 per share; there are no open-market purchases or sales reported in this filing.

Were the QMLS transactions for Dr. Akbari under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 trading plan for these transactions; they are reported as equity awards of restricted stock units rather than trades under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 06:22 PM EDT Accepted by SEC EDGAR 09/02/2026 - 06:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Akbari Dr. Homaira

(Last) (First) (Middle)

817 W. PEACHTREE STREET NW, SUITE 935

(Street)

ATLANTA GEORGIA 30308

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QumulusAI, Inc. [ QMLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		A		9,583(1)	A	$0	9,583	D
Common Stock	09/01/2026		A		6,038(2)	A	$0	15,621(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares vest with respect to 3,162 shares on October 1, 2026 and with respect to 8.375% of the remaining shares quarterly over 8 quarters commencing January 1, 2027 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI, Inc. through the applicable vesting date.

2. These shares vest on October 1, 2026 pursuant to a restricted stock unit award granted under the QumulusAI, Inc. 2026 Equity Incentive Plan.

3. Includes 15,621 shares to be issued upon vesting pursuant to restricted stock unit awards granted under the QumulusAI, Inc. 2026 Equity Incentive Plan, conditioned upon the Reporting Person remaining a director of QumulusAI through the applicable vesting dates.

	/s/ Homaira Akbari	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)